Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia

Not Applicable

Completed

• Conditions: Covid19; Lung Ultrasound; Pneumonia
• Interventions: Device: LUS Twelve area; Device: LUS Fourteen area

• Registration Number: NCT04805684
• Lead Sponsor: Bursa Yüksek İhtisas Education and Research Hospital

Brief Summary

Lung ultrasonography (LUS) is also used in COVID 19 pneumonia for diagnostic and follow-up purposes.It has been demonstrated in different studies that it can be used for pathologies in pleural and lung tissue. LUS was applied by different researchers by dividing the lungs into 12 and 14 regions and the results were shared.

Detailed Description

In our study, we aimed to determine the correlation between lung findings of COVID 19 pneumonia and thoracic tomography with the results of LUS applied to different numbers (12 versus 14) of areas.

Study Timeline

• Study Start: 2021-01-01
• Status Verified: 2021-03
• Primary Completion: 2021-03-05
• Study Completion: 2021-03-05
• Study First Submitted: 2021-03-15
• Study First Submitted QC: 2021-03-17
• Last Update Submitted: 2021-03-17
• Study First Posted: 2021-03-18
• Last Update Posted: 2021-03-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 59

Inclusion Criteria

• 18 and 85 years old
• Hospitalized in intensive care unit
• PCR (polymerase chain reaction) tested
• Thoracic CT applied

Exclusion Criteria

• Previous lung operation
• Thoracic wall disorder
• Interstitial lung disease
• Patients who did not consent to participate in the study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
lung ultrasound 12	LUS Twelve area	12 zone lung ultrasonography protocol
lung ultrasound 14	LUS Fourteen area	14 zone lung ultrasonography protocol

Primary Outcome Measures

Name	Time	Method
Correlation between Thoracic CT imaging results and LUS results	6 hours	Lung ultrasonography will be performed within 6 hours of the Thoracic CT.

Secondary Outcome Measures

Name	Time	Method
Characteristics of lesions	6 hours	Identifying the characteristics of the abnormal findings detected in Thoracic CT and LUS

Trial Locations

Locations (1)

University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital; 🇹🇷 Bursa, Turkey